Inside informationEnglish
Nicox’s NCX 470 Demonstrates Sustained Efficacy through 12 Months in Denali Clinical Trial with no new Safety Observations
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Nicox SA
- Filed
- 02/10/2025, 07:30
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 111036_20251002